UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Uncover wealth preservation strategies for retirees aimed at protecting your hard-earned assets. Secure your financial future with smart planning.
12,267 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A hedge fund made a sizable new bet on Centuri Holdings, disclosed in an SEC filing. This article breaks down the num...
A U.K.-based sustainability initiative drawing U.S. CEOs is reshaping how big companies commit to the energy transiti...
A disruption in the Strait of Hormuz could push crude higher and press on corporate profits. This guide explains the ...
Retail traders are rushing into oil bets as Iran-related tensions push prices higher, driving big fund inflows while ...
SoFi's Mastercard collaboration could unlock more than just card revenue. This article explains why the deal might ex...
Disney names Josh D’Amaro as CEO, effective March 18, 2026, ending a long succession saga. The new leader brings a un...
As Rivian gears up for the upcoming earnings release, two major catalysts could shape the stock's trajectory. This gu...
Investors are weighing Alibaba's prospects after a tough stretch. This guide examines whether alibaba stock rebound c...
Dave Ramsey delivered a blunt critique of financial planners on air, sparking a national debate about advisor fees an...
A 5% pullback in the Nasdaq in 2026 echoes big past moves and offers clues about which stocks tend to fare best durin...
Two popular international ETFs, EEM and IXUS, suit different goals. This guide explains how EEM offers focused growth...